NIM
BIIB icon

Northeast Investment Management’s Biogen BIIB Stock Holding History

Northeast Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,657
Closed -$431K – 156
2016
Q1 		$431K Sell
1,657
-218
-12% -$57.6K 0.04% 120
2015
Q4 		$574K Sell
1,875
-14,467
-89% -$4.16M 0.06% 113
2015
Q3 		$4.77M Buy
16,342
+2,710
+20% +$895K 0.51% 57
2015
Q2 		$5.51M Buy
13,632
+918
+7% +$368K 0.56% 53
2015
Q1 		$5.37M Buy
12,714
+2,903
+30% +$1.14M 0.53% 56
2014
Q4 		$3.33M Buy
9,811
+3,736
+61% +$1.21M 0.33% 70
2014
Q3 		$2.01M Buy
6,075
+3,349
+123% +$1.1M 0.2% 85
2014
Q2 		$860K Buy
+2,726
New +$820K 0.09% 110

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northeast Investment Management's BIIB Position: Q2 2016 in Review

Northeast Investment Management sold out of Biogen (BIIB) in Q2 2016, closing a stake of 1,657 shares — an estimated $431K sold.

Northeast Investment Management first reported a position in BIIB in Q2 2014 and held it in 8 quarters. The position peaked at $5.51M in Q2 2015. 967 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

  • Northeast Investment Management reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
  • Northeast Investment Management sold 1,657 Biogen shares in Q2 2016, an estimated $431K.
  • Northeast Investment Management first reported a position in Biogen in Q2 2014 and held it in 8 quarters.
  • Northeast Investment Management's Biogen position peaked at $5.51M in Q2 2015.
  • 967 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Northeast Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.